Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011 Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Working Life: Astellas Pharma Europe’s chief operating officer

January 4, 2011 Business Services, Sales and Marketing Astellas, Ken Jones, Working Life, recruitment

Ken Jones tells Pharmafocus about how his field is changing, starting with how he found his way into his current …

Italy: pioneering pay for performance in the age of austerity

January 4, 2011 Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts

2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …

US healthcare ‘extreme makeover’ predicted for 2011

December 31, 2010 Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC

Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …

VTE trial boost for Pfizer and BMS’ apixaban

December 31, 2010 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism

Pfizer and Bristol-Myers Squibb’s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …

GSK’s patient access scheme for Votrient sways NICE

December 24, 2010 Sales and Marketing GSK, GlaxoSmithKline, NICE, Votrient, pazopanib, rcc, renal cell carcinoma

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient in final draft guidance after the pharma company offered to implement a …

Novartis submits meningococcal vaccine Bexsero for European approval

December 23, 2010 Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine

Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …

2010: Pharma’s year in review

December 23, 2010 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review

2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …

PCTs look to save millions with new cuts

December 23, 2010 Sales and Marketing GP consortia, NHS, NHS cuts, NHS reforms, PCTs, generic prescribing

The NHS in England is cutting back on so-called ‘low priority’ procedures and looking to increase generic prescribing in order …

Novartis blood cancer drug impresses in late stage trial

December 22, 2010 Research and Development, Sales and Marketing INC424, Novartis, blood cancer, myelofibrosis, orphan drug

Novartis has released positive phase III results of its myelofibrosis drug INC424 showing it met its primary endpoint of reducing …

Liberating the NHS … whether it likes it or not

December 22, 2010 Sales and Marketing GP consortia, NHS, NHS board, NHS reforms, value-based pricing

When health secretary Andrew Lansley announced plans in July to abolish the management structure of England’s health service, and hand …

Roche to challenge FDA on Avastin

December 21, 2010 Sales and Marketing EMA, FDA, Roche, avastin, bevacizumab, breast cancer

Roche is set to challenge the decision by the FDA to remove a breast cancer indication from its blockbuster drug …

CRM and software-as-a-service

December 21, 2010 Sales and Marketing CRM, Dan Goldsmith, Service Insight, Veeva Systems

Service Insight from Dan Goldsmith, general manager, Europe, Veeva SystemsCriminal mastermind, Frank Abagnale Jr. (1901-1980), successfully conned millions of dollars …
AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor)

FDA delays approval of AstraZeneca’s Brilinta

December 20, 2010 Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome

US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …

Pharma careers options – management in China

December 17, 2010 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …
The Gateway to Local Adoption Series

Latest content